InvestorsHub Logo
Followers 8
Posts 1890
Boards Moderated 0
Alias Born 05/05/2016

Re: hopester post# 13907

Friday, 07/20/2018 12:25:44 PM

Friday, July 20, 2018 12:25:44 PM

Post# of 44784

You are spot on recognizing that competition is of significant concern.

No, he's not! I'll be concerned when the competition comes up with something even close to PLX-R18 in its broad support of reconstituting all cells lines after any kind of radiation damage. Only PLX-R18 can do that!

The only competition to PLX-PAD in CLI is revasc. surgery, not much of a competing therapy.

It's all about the POTENTIAL!!